Self-reported safety belt use among emergency department patients in Boston, Massachusetts.

BMC Public Health
William G FernandezJonathan Olshaker

Abstract

Safety belt use is 80% nationally, yet only 63% in Massachusetts. Safety belt use among potentially at-risk groups in Boston is unknown. We sought to assess the prevalence and correlates of belt non-use among emergency department (ED) patients in Boston. A cross-sectional survey with systematic sampling was conducted on non-urgent ED patients age > or = 18. A closed-ended survey was administered by interview. Safety belt use was defined via two methods: a single-item and a multiple-item measure of safety belt use. Each was scored using a 5-point frequency scale. Responses were used to categorize safety belt use as 'always' or less than 'always'. Outcome for multivariate logistic regression analysis was safety belt use less than 'always'. Of 478 patients approached, 381 (80%) participated. Participants were 48% female, 48% African-American, 40% White, median age 39. Among participants, 250 (66%) had been in a car crash; 234 (61%) had a valid driver's license, and 42 (11%) had been ticketed for belt non-use. Using two different survey measures, a single-item and a multiple-item measure, safety belt use 'always' was 51% and 36% respectively. According to separate regression models, factors associated with belt non-use included mal...Continue Reading

References

Jun 1, 1986·Accident; Analysis and Prevention·L Evans
May 1, 1994·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·E BernsteinS Krishel
Dec 1, 1993·Accident; Analysis and Prevention·D Shinar
Sep 1, 1997·Annals of Emergency Medicine·G M O'BrienR Woolard
Mar 1, 1996·Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention·D E Nelson
May 23, 1998·Accident; Analysis and Prevention·T S Dee
Aug 26, 1998·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·S R LowensteinM Blanda
Oct 31, 1998·Annals of Emergency Medicine·R H Lucas, S M Sanford
Aug 3, 1999·American Journal of Preventive Medicine·W LiangC Rohde
Aug 25, 1999·Annals of Emergency Medicine·T D PetersonR C Hunt
Feb 24, 2001·Accident; Analysis and Prevention·M A ParadaM Cortes
Apr 17, 2002·The Journal of Trauma·James Mayrose, Dietrich V K Jehle
Oct 23, 2002·The Journal of School Health·Jo Anne GrunbaumLloyd Kolbe
Nov 5, 2002·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Craig A WallsJae J Kennedy
Jun 5, 2004·Journal of Safety Research·James HedlundRuth A Shults
Sep 8, 2004·Accident; Analysis and Prevention·Jonathon M VivodaLidia P Kostyniuk
Dec 21, 2004·Drug and Alcohol Dependence·Judith BernsteinRalph Hingson
Apr 26, 2005·Addiction·Stephanie BlowsRobyn Norton
Jun 14, 2005·Accident; Analysis and Prevention·Stephanie BlowsRobyn Norton
Jul 1, 2005·Annals of Emergency Medicine·Shahrzad Bazargan-HejaziEdward Bernstein
Aug 19, 2007·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Steven L BernsteinGail D'Onofrio

❮ Previous
Next ❯

Citations

Jan 23, 2013·International Journal of Injury Control and Safety Promotion·Suleman Hadejia IdrisAmina Hassan
Apr 29, 2008·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·William G FernandezTed Colton
Apr 17, 2008·Addiction·José Lorenzo Valencia-MartínFernando Rodríguez-Artalejo
Jun 18, 2011·BMC Research Notes·Abiodun OlukogaAbayomi Odekunle
Aug 21, 2021·Accident; Analysis and Prevention·Jiachang GuXujun Zhang

❮ Previous
Next ❯

Software Mentioned

STATA
SE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.